This announcement is a separate document:
中外製薬：2023会計年度第3四半期の連結決算の補足資料。12（IFRS）
Chugai Pharmaceutical: Supplementary Materials for Consolidated Financial Results for the 3rd Quarter of Fiscal Year 2023. 12 (IFRS)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.